Brief: Avidity Partners Management Reports 9.9% Passive Stake In Syros Pharmaceuticals As Of Sept 16
20/09/2022 21:40
Sept 20 (Reuters) -
* AVIDITY PARTNERS MANAGEMENT LP REPORTS 9.9% PASSIVE STAKE
IN
SYROS PHARMACEUTICALS AS OF SEPT 16 - SEC FILING
Further company coverage: SYRS.O
Recent news on Syros Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
Syros Pharmaceuticals hits record low on QIAGEN deal termination and leadership changes
U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune
Syros falls after blood cancer drug fails in late-stage trial